MAXIM BIOTECH, INC. Company Profile

11:29 EDT 18th March 2018 | BioPortfolio

Maxim Biotech, Inc. was founded in July 1992 in the state of California. The principal office and R&D laboratory are located in South San Francisco, California. The San Francisco Bay Area is known for its biotechnology research and development, and companies located in this area dominate the biotechnology industry of the United States and worldwide. January 2006, Maxim Biotech has relocated its operation to Rockville Maryland, a 30,000 square feet space that is FDA approved cGMP manufacture facility.


1500 E. Gude Drive
United States of America


Phone: 301-217-0637
Fax: 301-217-9080

News Articles [1800 Associated News Articles listed on BioPortfolio]

Maxim's Target Price on Biotech Makes It More Than a Tenbagger

November 22, 2017 ( Newswire) Jason Kolbert, an analyst with Maxim Group, provided an update on this biopharmaceutical firm's two recently acquired oncology assets.

Maxim Healthcare Services Resolves Self-Disclosed Billing Error with MassHealth

The settlement refunds overpayments from MassHealth for home health aide services Maxim provided to certain MassHealth beneficiaries between 2010 and 2016. Maxim discovered and self-reported Read ...

Biotech Receives Device Approval in Five More Countries; Revenue Up 122% YOY

October 25, 2017 ( Newswire) Maxim Group reported on this firm's Q3/17 earnings, as well as its progress in obtaining international regulatory clearances for its medical system.

Gilead Sciences sorgt für Eindruck! - Aktienanalyse

New York - Gilead Sciences-Aktienanalyse des Analysten Jason McCarthy von Maxim Group: Jason McCarthy, Aktienanalyst von Maxim Group, empfiehlt die Aktien des US-Biotechkonzerns Gilead Sciences Inc...

Biotech Advances Potential 'Billion-Dollar Drug' with New Trial Launch in China

December 7, 2017 ( Newswire) Maxim Group analyst Jason Kolbert discussed what the launch of a clinical trial in China means for this developer of immuno-oncology therapies.

Streetwise Reports Examines Biotech Company that Receives Device Approval in Five More Countries and Revenue Increases 122% YOY

SAN FRANCISCO, CA--(Marketwired - October 26, 2017) - Maxim Group reported on this firm's Q3/17 earnings, as well as its progress in obtaining international regulatory clearances for its medical syst...

BB Biotech: Viele wichtige News 2018

Die Schweizer Biotech-Beteiligungsgesellschaft BB Biotech hat am Freitag den Geschäftsbericht 2017 veröffentlicht. Wieder einmal ist der dem Unternehmen die Benchmark Nasdaq Biotech Index zu schlag....

Despite Spike, Why Investors Should Still Avoid MannKind Like the Plague

MannKind could be sent to dilute shares in a significant manner, warns Maxim analyst Jason Kolbert in a research note released today.

Drugs and Medications [8 Associated Drugs and Medications listed on BioPortfolio]

Ocufresh [Taiwan Biotech Co, Ltd]

Minidrops [Taiwan Biotech Co, Ltd]

Iman time control all day moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Iman time control oil free moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Stelara [Janssen Biotech, Inc.]

These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) Injection, for subcutaneous useIn...

PubMed Articles [46 Associated PubMed Articles listed on BioPortfolio]

Biotech Crop Planting Resumes High Adoption in 2016.

The global area of biotech crops in 2016 increased from 179.7 million hectares to 185.1 million hectares, a 3% increase equivalent to 5.4 million hectares. Some 26 countries planted biotech crops, 19 ...

Just how good an investment is the biopharmaceutical sector?

Uncertainty surrounding the risk and reward of investments in biopharmaceutical companies poses a challenge to those interested in funding such enterprises. Using data on publicly traded stocks, we tr...

On the biotech block.

Second-quarter biotech job picture.

Third-quarter biotech job picture.

Clinical Trials [16 Associated Clinical Trials listed on BioPortfolio]

Maxim® Knee Pop-Top® Tibia vs. Regular Maxim® Knee Tibia

The purpose of this prospective clinical data collection is to compare the outcomes of two different tibial bearings: the Maxim® Pop-Top® Tibia and Maxim® Modular Tibia.

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

The purpose of this single-centre, randomized, double-blind, parallel control, phase 3 study is to evaluate the safety and immunogenicity of a rabies vaccine (Vero Cell) for human use in h...

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is based on a combination of the PeviPRO and PeviTER pl...

A Comparison of the Design of Tibia Stems in Cemented Total Knee Arthroplasty - Wedge Stem Versus I-Beam Stem.

The purpose of this study is to compare the early migration and periprosthetic bone changes of two cemented total knee arthroplasties with different tibial stem design. Only the tibial pro...

Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine

The purpose of this study is to evaluate the 5-year Immune Persistence of Inactivated Enterovirus Type 71 (EV71) Vaccine manufactured by Sinovac (Beijing) Biotech Co., Ltd.

Companies [897 Associated Companies listed on BioPortfolio]


Maxim Biotech, Inc. was founded in July 1992 in the state of California. The principal office and R&D laboratory are located in South San Francisco, California. The San Francisco Bay Area is known for...

Maxim Partners, LLC

Founded in 1991, Maxim is a Chicago-based private equity firm dedicated to lower middle-market private growth companies in the Education, Environmental, Energy and Wellness indust...

Maxim Health Systems

Maxim Health Systems is a division of Maxim Healthcare Services, Inc. Established in 1996, Maxim Health Systems offers a full line of comprehensive wellness services to corporate and retail clients, ...

Maxim Pharmaceuticals Incorporated

Maxim Pharmaceuticals, Inc. is a global biopharmaceutical company with a strong pipeline of product candidates addressing cancer, hepatitis and other liver diseases. To date, Maxim has generated a si...

Maxim Healthcare Services

Founded in 2001, Reflectx Staffing a division of Maxim Healthcare Services is a unique staffing company that exclusively provides rehabilitation therapy professionals. Recognized in 2007 by Entreprene...

More Information about "MAXIM BIOTECH, INC." on BioPortfolio

We have published hundreds of MAXIM BIOTECH, INC. news stories on BioPortfolio along with dozens of MAXIM BIOTECH, INC. Clinical Trials and PubMed Articles about MAXIM BIOTECH, INC. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MAXIM BIOTECH, INC. Companies in our database. You can also find out about relevant MAXIM BIOTECH, INC. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record